Related Experiment Video
Updated: Oct 5, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Outcomes of Arterial Embolization vs Covered Stents for Delayed Massive Hemorrhage After Pancreatic or Biliary
Yukihiro Watanabe1, Ken Nakazawa2, Kenichiro Takase3
1Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, 1397-1 Yamane350-1298, Japan. watanb@saitama-med.ac.jp.
Insights
Covered stent placement (CSP) is a superior endovascular treatment for delayed massive hemorrhage (DMH) after pancreatic or biliary surgery. CSP significantly reduces major hepatic complications and mortality compared to arterial embolization (AE).
Area of Science:
- Interventional Radiology
- Vascular Surgery
- Hepatobiliary Surgery
Background:
- Delayed massive hemorrhage (DMH) is a serious complication following pancreatic or biliary surgery.
- Covered stent placement (CSP) is increasingly used for DMH management, but its benefits require further evaluation.
- Conflicting results exist regarding the efficacy of CSP versus traditional methods.
Purpose of the Study:
- To compare the short- and medium-term outcomes of arterial embolization (AE) and CSP for managing DMH.
- To assess the effectiveness of endovascular treatments for hepatic artery hemorrhage post-pancreaticobiliary surgery.
Main Methods:
- Retrospective analysis of patients treated with AE (n=50) or CSP (n=20) for DMH from January 2009 to December 2019.
- Evaluation of major hepatic complications, in-hospital mortality, and 1-year mortality.
- Analysis of factors including age, sex, reintervention, arterial variants, and portal vein stenosis.
Main Results:
- CSP demonstrated no in-hospital mortality versus 32% for AE (p=0.003).
- CSP showed significantly lower rates of major hepatic complications (10% vs. 44%, p=0.011) and 1-year mortality (25% vs. 54%, p=0.035) compared to AE.
- Technical success and reintervention rates were similar between CSP and AE.
Conclusions:
- Covered stent placement is superior to arterial embolization for managing delayed massive hemorrhage from hepatic arteries.
- CSP significantly reduces major hepatic complications and mortality in this patient population.
- CSP offers improved outcomes for patients experiencing DMH after pancreatic or biliary surgery.
Background:
Covered stent placement (CSP) is gaining popularity for the management of delayed massive hemorrhage (DMH) after pancreatic or biliary surgery. However, early studies have produced conflicting results regarding the potential advantages of the procedure. We aimed to compare the short- and medium-term outcomes of arterial embolization (AE) and CSP for DMH.
Methods:
We analyzed data for patients who underwent AE or CSP as an endovascular treatment (EVT) for DMH from the common hepatic artery (CHA) and its distal arteries between January 2009 and December 2019. We evaluated the major hepatic complications, in-hospital mortality, and 1-year mortality associated with the procedures, according to age, sex, reintervention, arterial variant, interval between surgery and EVT, and portal vein stenosis.
Results:
All hemorrhages were treated using AE (n = 50) or CSP (n = 20). CSP was associated with no in-hospital mortality (32% vs. 0%, p = 0.003), and lower incidences of major hepatic complications (44% vs. 10%, p = 0.011) and 1-year mortality (54% vs. 25%, p = 0.035) compared with AE, respectively. There was no significant difference in technical success and reintervention rates. Compared with AE, the risk-adjusted odds ratios for CSP (95% confidence intervals) for major hepatic complications and 1-year mortality were 0.06 (0.01-0.39) and 0.19 (0.05-0.71), respectively.
Conclusions:
CSP is superior to AE regarding major hepatic complications and in-hospital- and 1-year mortality in patients with DMH from hepatic arteries.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
